Company intelligence / Profile preview

Cellect Biotechnology Ltd.

Ownership: Private
Development stage: Other

Overview

Prior to its merger, Cellect Biotechnology developed the ApoGraft platform, which aimed to improve the safety and efficacy of regenerative medicine and stem cell therapies by functionally selecting high-quality stem cells. The company had not yet commercialized any products or generated revenue before being acquired in a reverse merger by Quoin Pharmaceuticals in October 2021.[4][7]

Therapeutic areas: OtherHematology
Modalities: Stem cellsCell therapy selection technologiesRegenerative medicine platforms
Industry: Biotech

Partnerships

denovoMATRIX group at Technische Universität Dresden (collaborative product development for regenerative medicine)Cell2in Inc. (combining technologies for monitoring and improving stem cell quality)XNK Therapeutics AB (development focused on NK-cell based therapeutics)[2]Advisors during strategic transactions included JMP Securities and Cassel Salpeter & Co. [5]

Beyond the preview

Go deeper on Cellect Biotechnology Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellect Biotechnology Ltd..